Share Price and Basic Stock Data
Last Updated: September 5, 2025, 4:23 pm
PEG Ratio | 0.44 |
---|
Quick Insight
Gujarat Fluorochemicals Ltd's current market cap stands at ₹37,639 Cr., with a P/E ratio of 60.5, indicating a relatively high valuation compared to its earnings. The company's Return on Equity (ROE) is 8.28%, while Return on Capital Employed (ROCE) is slightly higher at 9.88%, suggesting efficient use of capital. Operating Profit Margin (OPM) is healthy at 27%, contributing to a Net Profit of ₹546 Cr. The firm boasts significant reserves of ₹7,242 Cr. but also carries substantial borrowings of ₹2,080 Cr., resulting in a high Price-to-Book Value (P/BV) ratio of 5.73x. With an Interest Coverage Ratio (ICR) of 7.62x, Gujarat Fluorochemicals Ltd appears to manage its debt obligations well. However, the Cash Conversion Cycle (CCC) of 392 days warrants attention for potential efficiency improvements. In conclusion, while the company shows promise in profitability and capital efficiency, monitoring its debt levels and operational cash flow management will be crucial for sustained growth.
Competitors of Gujarat Fluorochemicals Ltd
Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
---|---|---|---|---|---|---|---|---|---|
HP Adhesives Ltd | 417 Cr. | 45.7 | 102/42.6 | 25.4 | 20.0 | 0.87 % | 13.9 % | 10.1 % | 2.00 |
Haryana Leather Chemicals Ltd | 35.9 Cr. | 73.1 | 124/56.0 | 16.0 | 87.4 | 1.36 % | 8.02 % | 5.45 % | 10.0 |
Hardcastle & Waud Mfg Co Ltd | 52.1 Cr. | 767 | 1,178/600 | 56.7 | 670 | 0.00 % | 6.20 % | 2.87 % | 10.0 |
Grauer & Weil (India) Ltd | 4,239 Cr. | 93.5 | 120/78.0 | 28.2 | 20.7 | 0.52 % | 23.3 % | 17.6 % | 1.00 |
DMCC Speciality Chemicals Ltd | 769 Cr. | 308 | 453/241 | 27.6 | 91.1 | 0.81 % | 14.1 % | 9.97 % | 10.0 |
Industry Average | 12,957.32 Cr | 769.19 | 46.56 | 179.72 | 0.40% | 13.05% | 25.67% | 6.44 |
Quarterly Result
Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 1,334 | 1,461 | 1,418 | 1,471 | 1,209 | 947 | 992 | 1,133 | 1,176 | 1,188 | 1,148 | 1,225 | 1,281 |
Expenses | 875 | 926 | 895 | 942 | 861 | 783 | 786 | 895 | 914 | 893 | 854 | 919 | 937 |
Operating Profit | 459 | 536 | 523 | 529 | 348 | 164 | 206 | 238 | 262 | 295 | 294 | 306 | 344 |
OPM % | 34% | 37% | 37% | 36% | 29% | 17% | 21% | 21% | 22% | 25% | 26% | 25% | 27% |
Other Income | 26 | 24 | 21 | 19 | 15 | 13 | 13 | 18 | 9 | 9 | 14 | 26 | 23 |
Interest | 21 | 23 | 38 | 35 | 28 | 34 | 37 | 34 | 37 | 42 | 42 | 26 | 30 |
Depreciation | 55 | 57 | 60 | 64 | 66 | 68 | 72 | 81 | 85 | 90 | 91 | 89 | 90 |
Profit before tax | 409 | 480 | 446 | 449 | 269 | 75 | 110 | 141 | 149 | 172 | 175 | 217 | 247 |
Tax % | 26% | 26% | 26% | 26% | 25% | 29% | 27% | 28% | 28% | 30% | 28% | 12% | 26% |
Net Profit | 303 | 357 | 331 | 332 | 201 | 53 | 80 | 101 | 108 | 121 | 126 | 191 | 184 |
EPS in Rs | 27.88 | 32.88 | 29.99 | 30.21 | 18.30 | 4.82 | 7.28 | 9.19 | 9.83 | 11.02 | 11.47 | 17.39 | 16.75 |
Last Updated: August 20, 2025, 10:00 am
Below is a detailed analysis of the quarterly data for Gujarat Fluorochemicals Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 1,281.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,225.00 Cr. (Mar 2025) to 1,281.00 Cr., marking an increase of 56.00 Cr..
- For Expenses, as of Jun 2025, the value is 937.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 919.00 Cr. (Mar 2025) to 937.00 Cr., marking an increase of 18.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 344.00 Cr.. The value appears strong and on an upward trend. It has increased from 306.00 Cr. (Mar 2025) to 344.00 Cr., marking an increase of 38.00 Cr..
- For OPM %, as of Jun 2025, the value is 27.00%. The value appears strong and on an upward trend. It has increased from 25.00% (Mar 2025) to 27.00%, marking an increase of 2.00%.
- For Other Income, as of Jun 2025, the value is 23.00 Cr.. The value appears to be declining and may need further review. It has decreased from 26.00 Cr. (Mar 2025) to 23.00 Cr., marking a decrease of 3.00 Cr..
- For Interest, as of Jun 2025, the value is 30.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 26.00 Cr. (Mar 2025) to 30.00 Cr., marking an increase of 4.00 Cr..
- For Depreciation, as of Jun 2025, the value is 90.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 89.00 Cr. (Mar 2025) to 90.00 Cr., marking an increase of 1.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 247.00 Cr.. The value appears strong and on an upward trend. It has increased from 217.00 Cr. (Mar 2025) to 247.00 Cr., marking an increase of 30.00 Cr..
- For Tax %, as of Jun 2025, the value is 26.00%. The value appears to be increasing, which may not be favorable. It has increased from 12.00% (Mar 2025) to 26.00%, marking an increase of 14.00%.
- For Net Profit, as of Jun 2025, the value is 184.00 Cr.. The value appears to be declining and may need further review. It has decreased from 191.00 Cr. (Mar 2025) to 184.00 Cr., marking a decrease of 7.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 16.75. The value appears to be declining and may need further review. It has decreased from 17.39 (Mar 2025) to 16.75, marking a decrease of 0.64.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: July 22, 2025, 3:45 pm
Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
---|---|---|---|---|---|---|---|---|
Sales | 3,851 | 2,729 | 2,606 | 2,650 | 3,954 | 5,685 | 4,281 | 4,737 |
Expenses | 3,105 | 1,941 | 2,167 | 2,052 | 2,785 | 3,719 | 3,366 | 3,580 |
Operating Profit | 745 | 788 | 439 | 598 | 1,168 | 1,965 | 915 | 1,157 |
OPM % | 19% | 29% | 17% | 23% | 30% | 35% | 21% | 24% |
Other Income | 112 | 78 | 190 | 199 | 161 | 172 | 100 | 58 |
Interest | 279 | 56 | 105 | 113 | 78 | 117 | 133 | 147 |
Depreciation | 299 | 164 | 192 | 202 | 205 | 236 | 286 | 355 |
Profit before tax | 279 | 645 | 332 | 482 | 1,045 | 1,785 | 595 | 713 |
Tax % | 14% | -93% | 43% | 146% | 26% | 26% | 27% | 23% |
Net Profit | 240 | 1,246 | 189 | -222 | 776 | 1,323 | 435 | 546 |
EPS in Rs | 17.87 | -19.91 | 71.66 | 120.97 | 39.59 | 49.70 | ||
Dividend Payout % | 15% | 0% | 0% | 0% | 6% | 3% | 8% | 6% |
YoY Net Profit Growth
Year | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
---|---|---|---|---|---|---|---|
YoY Net Profit Growth (%) | 419.17% | -84.83% | -217.46% | 449.55% | 70.49% | -67.12% | 25.52% |
Change in YoY Net Profit Growth (%) | 0.00% | -504.00% | -132.63% | 667.01% | -379.06% | -137.61% | 92.64% |
Gujarat Fluorochemicals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 7 years from 2018-2019 to 2024-2025.
Growth
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 13% |
3 Years: | 6% |
TTM: | 14% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 21% |
3 Years: | -11% |
TTM: | 82% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | 45% |
3 Years: | 0% |
1 Year: | -4% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 12% |
3 Years: | 13% |
Last Year: | 8% |
Last Updated: September 5, 2025, 5:35 am
Balance Sheet
Last Updated: July 25, 2025, 3:08 pm
Month | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
---|---|---|---|---|---|---|---|---|
Equity Capital | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 |
Reserves | 4,756 | 3,499 | 3,705 | 3,482 | 4,244 | 5,510 | 5,925 | 7,242 |
Borrowings | 2,000 | 968 | 1,718 | 1,581 | 1,556 | 1,515 | 2,096 | 2,080 |
Other Liabilities | 2,986 | 441 | 634 | 895 | 1,067 | 1,335 | 1,201 | 1,276 |
Total Liabilities | 9,753 | 4,919 | 6,067 | 5,969 | 6,878 | 8,371 | 9,233 | 10,609 |
Fixed Assets | 3,813 | 2,305 | 2,414 | 2,367 | 2,514 | 3,111 | 4,264 | 4,329 |
CWIP | 724 | 229 | 318 | 400 | 680 | 1,158 | 1,128 | 1,524 |
Investments | 524 | 342 | 259 | 88 | 20 | 1 | 1 | 290 |
Other Assets | 4,691 | 2,042 | 3,076 | 3,114 | 3,665 | 4,101 | 3,840 | 4,466 |
Total Assets | 9,753 | 4,919 | 6,067 | 5,969 | 6,878 | 8,371 | 9,233 | 10,609 |
Below is a detailed analysis of the balance sheet data for Gujarat Fluorochemicals Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 11.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 11.00 Cr..
- For Reserves, as of Mar 2025, the value is 7,242.00 Cr.. The value appears strong and on an upward trend. It has increased from 5,925.00 Cr. (Mar 2024) to 7,242.00 Cr., marking an increase of 1,317.00 Cr..
- For Borrowings, as of Mar 2025, the value is 2,080.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 2,096.00 Cr. (Mar 2024) to 2,080.00 Cr., marking a decrease of 16.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 1,276.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,201.00 Cr. (Mar 2024) to 1,276.00 Cr., marking an increase of 75.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 10,609.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 9,233.00 Cr. (Mar 2024) to 10,609.00 Cr., marking an increase of 1,376.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 4,329.00 Cr.. The value appears strong and on an upward trend. It has increased from 4,264.00 Cr. (Mar 2024) to 4,329.00 Cr., marking an increase of 65.00 Cr..
- For CWIP, as of Mar 2025, the value is 1,524.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,128.00 Cr. (Mar 2024) to 1,524.00 Cr., marking an increase of 396.00 Cr..
- For Investments, as of Mar 2025, the value is 290.00 Cr.. The value appears strong and on an upward trend. It has increased from 1.00 Cr. (Mar 2024) to 290.00 Cr., marking an increase of 289.00 Cr..
- For Other Assets, as of Mar 2025, the value is 4,466.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,840.00 Cr. (Mar 2024) to 4,466.00 Cr., marking an increase of 626.00 Cr..
- For Total Assets, as of Mar 2025, the value is 10,609.00 Cr.. The value appears strong and on an upward trend. It has increased from 9,233.00 Cr. (Mar 2024) to 10,609.00 Cr., marking an increase of 1,376.00 Cr..
Notably, the Reserves (7,242.00 Cr.) exceed the Borrowings (2,080.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
Month | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
---|---|---|---|---|---|---|---|---|
Free Cash Flow
Month | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
---|---|---|---|---|---|---|---|---|
Free Cash Flow | 743.00 | -180.00 | 438.00 | 597.00 | 0.00 | 0.00 | 913.00 | -1.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
Month | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
---|---|---|---|---|---|---|---|---|
Debtor Days | 184 | 77 | 79 | 92 | 72 | 71 | 72 | 92 |
Inventory Days | 736 | 351 | 390 | 404 | 314 | 375 | 435 | 449 |
Days Payable | 471 | 127 | 176 | 159 | 170 | 174 | 144 | 149 |
Cash Conversion Cycle | 449 | 301 | 293 | 338 | 216 | 272 | 363 | 392 |
Working Capital Days | 67 | 22 | -0 | 6 | 33 | 62 | 60 | 119 |
ROCE % | 11% | 9% | 11% | 20% | 30% | 10% | 10% |
Mutual Fund Holdings
Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
---|---|---|---|---|---|---|
HDFC Mid-Cap Opportunities Fund - Regular Plan | 1,990,000 | 1.09 | 567.38 | 1,990,000 | 2025-04-22 13:31:13 | 0% |
Mirae Asset Focused Fund | 806,119 | 2.53 | 229.84 | 806,119 | 2025-04-22 17:25:34 | 0% |
DSP Flexi Cap Fund | 762,208 | 2.3 | 217.32 | 762,208 | 2025-04-22 17:25:34 | 0% |
DSP Equity & Bond Fund | 528,892 | 1.79 | 150.8 | 528,892 | 2025-04-22 17:25:34 | 0% |
Aditya Birla Sun Life Midcap Fund | 457,307 | 2.82 | 130.39 | 457,307 | 2025-04-22 15:56:57 | 0% |
DSP ELSS Tax Saver Fund | 435,648 | 0.98 | 124.21 | 435,648 | 2025-04-22 17:25:34 | 0% |
DSP Equity Opportunities Fund | 389,579 | 1.15 | 111.07 | 389,579 | 2025-04-22 17:25:34 | 0% |
Nippon India Growth Fund | 374,595 | 0.5 | 106.8 | 374,595 | 2025-04-22 17:25:34 | 0% |
Nippon India Small Cap Fund | 281,735 | 0.2 | 80.33 | 281,735 | 2025-04-22 17:25:34 | 0% |
Aditya Birla Sun Life Flexi Cap Fund | 281,258 | 0.44 | 80.19 | 281,258 | 2025-04-22 17:25:34 | 0% |
Key Financial Ratios
Month | Mar 24 | Mar 23 | Mar 22 | Mar 21 | Mar 20 |
---|---|---|---|---|---|
FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
Basic EPS (Rs.) | 39.60 | 120.44 | 70.63 | -20.17 | 17.23 |
Diluted EPS (Rs.) | 39.60 | 120.44 | 70.63 | -20.17 | 17.23 |
Cash EPS (Rs.) | 65.64 | 141.93 | 89.33 | -1.77 | 34.75 |
Book Value[Excl.RevalReserv]/Share (Rs.) | 540.40 | 502.57 | 385.10 | 316.70 | 337.27 |
Book Value[Incl.RevalReserv]/Share (Rs.) | 540.40 | 502.57 | 385.10 | 316.70 | 337.27 |
Revenue From Operations / Share (Rs.) | 389.70 | 517.49 | 359.91 | 241.28 | 237.27 |
PBDIT / Share (Rs.) | 92.33 | 194.59 | 120.99 | 72.55 | 59.66 |
PBIT / Share (Rs.) | 66.29 | 173.10 | 102.28 | 54.16 | 42.14 |
PBT / Share (Rs.) | 54.17 | 162.47 | 95.15 | 43.91 | 30.23 |
Net Profit / Share (Rs.) | 39.60 | 120.44 | 70.63 | -20.17 | 17.23 |
NP After MI And SOA / Share (Rs.) | 39.60 | 120.97 | 71.66 | -19.91 | 17.87 |
PBDIT Margin (%) | 23.69 | 37.60 | 33.61 | 30.06 | 25.14 |
PBIT Margin (%) | 17.01 | 33.45 | 28.41 | 22.44 | 17.76 |
PBT Margin (%) | 13.90 | 31.39 | 26.43 | 18.19 | 12.74 |
Net Profit Margin (%) | 10.16 | 23.27 | 19.62 | -8.35 | 7.26 |
NP After MI And SOA Margin (%) | 10.16 | 23.37 | 19.91 | -8.25 | 7.53 |
Return on Networth / Equity (%) | 7.32 | 24.06 | 18.49 | -6.26 | 5.28 |
Return on Capital Employeed (%) | 10.81 | 31.52 | 22.60 | 14.23 | 10.96 |
Return On Assets (%) | 4.71 | 15.87 | 11.44 | -3.66 | 3.23 |
Long Term Debt / Equity (X) | 0.06 | 0.03 | 0.10 | 0.11 | 0.12 |
Total Debt / Equity (X) | 0.33 | 0.26 | 0.36 | 0.40 | 0.40 |
Asset Turnover Ratio (%) | 0.48 | 0.74 | 0.59 | 0.42 | 0.45 |
Current Ratio (X) | 1.36 | 1.50 | 1.28 | 1.08 | 1.05 |
Quick Ratio (X) | 0.73 | 0.86 | 0.78 | 0.59 | 0.60 |
Inventory Turnover Ratio (X) | 1.52 | 2.61 | 2.28 | 1.73 | 2.19 |
Dividend Payout Ratio (NP) (%) | 5.05 | 3.30 | 2.79 | 0.00 | 0.00 |
Dividend Payout Ratio (CP) (%) | 3.04 | 2.80 | 2.21 | 0.00 | 0.00 |
Earning Retention Ratio (%) | 94.95 | 96.70 | 97.21 | 0.00 | 0.00 |
Cash Earning Retention Ratio (%) | 96.96 | 97.20 | 97.79 | 0.00 | 0.00 |
Interest Coverage Ratio (X) | 7.62 | 18.30 | 16.95 | 7.08 | 6.25 |
Interest Coverage Ratio (Post Tax) (X) | 4.27 | 12.33 | 10.90 | -0.96 | 3.06 |
Enterprise Value (Cr.) | 35822.28 | 34443.07 | 31565.58 | 7693.95 | 4678.76 |
EV / Net Operating Revenue (X) | 8.37 | 6.06 | 7.98 | 2.90 | 1.80 |
EV / EBITDA (X) | 35.32 | 16.11 | 23.75 | 9.65 | 7.14 |
MarketCap / Net Operating Revenue (X) | 7.95 | 5.83 | 7.64 | 2.38 | 1.22 |
Retention Ratios (%) | 94.94 | 96.69 | 97.20 | 0.00 | 0.00 |
Price / BV (X) | 5.73 | 6.00 | 7.10 | 1.81 | 0.85 |
Price / Net Operating Revenue (X) | 7.95 | 5.83 | 7.64 | 2.38 | 1.22 |
EarningsYield | 0.01 | 0.04 | 0.02 | -0.03 | 0.06 |
After reviewing the key financial ratios for Gujarat Fluorochemicals Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 24, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 1.00.
- For Basic EPS (Rs.), as of Mar 24, the value is 39.60. This value is within the healthy range. It has decreased from 120.44 (Mar 23) to 39.60, marking a decrease of 80.84.
- For Diluted EPS (Rs.), as of Mar 24, the value is 39.60. This value is within the healthy range. It has decreased from 120.44 (Mar 23) to 39.60, marking a decrease of 80.84.
- For Cash EPS (Rs.), as of Mar 24, the value is 65.64. This value is within the healthy range. It has decreased from 141.93 (Mar 23) to 65.64, marking a decrease of 76.29.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 540.40. It has increased from 502.57 (Mar 23) to 540.40, marking an increase of 37.83.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 540.40. It has increased from 502.57 (Mar 23) to 540.40, marking an increase of 37.83.
- For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 389.70. It has decreased from 517.49 (Mar 23) to 389.70, marking a decrease of 127.79.
- For PBDIT / Share (Rs.), as of Mar 24, the value is 92.33. This value is within the healthy range. It has decreased from 194.59 (Mar 23) to 92.33, marking a decrease of 102.26.
- For PBIT / Share (Rs.), as of Mar 24, the value is 66.29. This value is within the healthy range. It has decreased from 173.10 (Mar 23) to 66.29, marking a decrease of 106.81.
- For PBT / Share (Rs.), as of Mar 24, the value is 54.17. This value is within the healthy range. It has decreased from 162.47 (Mar 23) to 54.17, marking a decrease of 108.30.
- For Net Profit / Share (Rs.), as of Mar 24, the value is 39.60. This value is within the healthy range. It has decreased from 120.44 (Mar 23) to 39.60, marking a decrease of 80.84.
- For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 39.60. This value is within the healthy range. It has decreased from 120.97 (Mar 23) to 39.60, marking a decrease of 81.37.
- For PBDIT Margin (%), as of Mar 24, the value is 23.69. This value is within the healthy range. It has decreased from 37.60 (Mar 23) to 23.69, marking a decrease of 13.91.
- For PBIT Margin (%), as of Mar 24, the value is 17.01. This value is within the healthy range. It has decreased from 33.45 (Mar 23) to 17.01, marking a decrease of 16.44.
- For PBT Margin (%), as of Mar 24, the value is 13.90. This value is within the healthy range. It has decreased from 31.39 (Mar 23) to 13.90, marking a decrease of 17.49.
- For Net Profit Margin (%), as of Mar 24, the value is 10.16. This value exceeds the healthy maximum of 10. It has decreased from 23.27 (Mar 23) to 10.16, marking a decrease of 13.11.
- For NP After MI And SOA Margin (%), as of Mar 24, the value is 10.16. This value is within the healthy range. It has decreased from 23.37 (Mar 23) to 10.16, marking a decrease of 13.21.
- For Return on Networth / Equity (%), as of Mar 24, the value is 7.32. This value is below the healthy minimum of 15. It has decreased from 24.06 (Mar 23) to 7.32, marking a decrease of 16.74.
- For Return on Capital Employeed (%), as of Mar 24, the value is 10.81. This value is within the healthy range. It has decreased from 31.52 (Mar 23) to 10.81, marking a decrease of 20.71.
- For Return On Assets (%), as of Mar 24, the value is 4.71. This value is below the healthy minimum of 5. It has decreased from 15.87 (Mar 23) to 4.71, marking a decrease of 11.16.
- For Long Term Debt / Equity (X), as of Mar 24, the value is 0.06. This value is below the healthy minimum of 0.2. It has increased from 0.03 (Mar 23) to 0.06, marking an increase of 0.03.
- For Total Debt / Equity (X), as of Mar 24, the value is 0.33. This value is within the healthy range. It has increased from 0.26 (Mar 23) to 0.33, marking an increase of 0.07.
- For Asset Turnover Ratio (%), as of Mar 24, the value is 0.48. It has decreased from 0.74 (Mar 23) to 0.48, marking a decrease of 0.26.
- For Current Ratio (X), as of Mar 24, the value is 1.36. This value is below the healthy minimum of 1.5. It has decreased from 1.50 (Mar 23) to 1.36, marking a decrease of 0.14.
- For Quick Ratio (X), as of Mar 24, the value is 0.73. This value is below the healthy minimum of 1. It has decreased from 0.86 (Mar 23) to 0.73, marking a decrease of 0.13.
- For Inventory Turnover Ratio (X), as of Mar 24, the value is 1.52. This value is below the healthy minimum of 4. It has decreased from 2.61 (Mar 23) to 1.52, marking a decrease of 1.09.
- For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 5.05. This value is below the healthy minimum of 20. It has increased from 3.30 (Mar 23) to 5.05, marking an increase of 1.75.
- For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 3.04. This value is below the healthy minimum of 20. It has increased from 2.80 (Mar 23) to 3.04, marking an increase of 0.24.
- For Earning Retention Ratio (%), as of Mar 24, the value is 94.95. This value exceeds the healthy maximum of 70. It has decreased from 96.70 (Mar 23) to 94.95, marking a decrease of 1.75.
- For Cash Earning Retention Ratio (%), as of Mar 24, the value is 96.96. This value exceeds the healthy maximum of 70. It has decreased from 97.20 (Mar 23) to 96.96, marking a decrease of 0.24.
- For Interest Coverage Ratio (X), as of Mar 24, the value is 7.62. This value is within the healthy range. It has decreased from 18.30 (Mar 23) to 7.62, marking a decrease of 10.68.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 4.27. This value is within the healthy range. It has decreased from 12.33 (Mar 23) to 4.27, marking a decrease of 8.06.
- For Enterprise Value (Cr.), as of Mar 24, the value is 35,822.28. It has increased from 34,443.07 (Mar 23) to 35,822.28, marking an increase of 1,379.21.
- For EV / Net Operating Revenue (X), as of Mar 24, the value is 8.37. This value exceeds the healthy maximum of 3. It has increased from 6.06 (Mar 23) to 8.37, marking an increase of 2.31.
- For EV / EBITDA (X), as of Mar 24, the value is 35.32. This value exceeds the healthy maximum of 15. It has increased from 16.11 (Mar 23) to 35.32, marking an increase of 19.21.
- For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 7.95. This value exceeds the healthy maximum of 3. It has increased from 5.83 (Mar 23) to 7.95, marking an increase of 2.12.
- For Retention Ratios (%), as of Mar 24, the value is 94.94. This value exceeds the healthy maximum of 70. It has decreased from 96.69 (Mar 23) to 94.94, marking a decrease of 1.75.
- For Price / BV (X), as of Mar 24, the value is 5.73. This value exceeds the healthy maximum of 3. It has decreased from 6.00 (Mar 23) to 5.73, marking a decrease of 0.27.
- For Price / Net Operating Revenue (X), as of Mar 24, the value is 7.95. This value exceeds the healthy maximum of 3. It has increased from 5.83 (Mar 23) to 7.95, marking an increase of 2.12.
- For EarningsYield, as of Mar 24, the value is 0.01. This value is below the healthy minimum of 5. It has decreased from 0.04 (Mar 23) to 0.01, marking a decrease of 0.03.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Strength | Weakness |
---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Gujarat Fluorochemicals Ltd:
- Net Profit Margin: 10.16%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 10.81% (Industry Average ROCE: 13.05%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 7.32% (Industry Average ROE: 25.67%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 4.27
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.73
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 59.6 (Industry average Stock P/E: 46.56)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.33
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 10.16%
About the Company - Qualitative Analysis
INDUSTRY | ADDRESS | CONTACT |
---|---|---|
Chemicals - Speciality - Others | Survey No 16/3, 26 and 27, Village Ranjitnagar, Panchmahal District Gujarat 389380 | bvdesai@gfl.co.in http://www.gfl.co.in |
Management | |
---|---|
Name | Position Held |
Mr. Devendra Kumar Jain | Chairman & Non Independent Director |
Mr. Vivek Kumar Jain | Managing Director |
Dr. Bir Kapoor | Deputy Managing Director |
Mr. Sanath Kumar Muppirala | Whole Time Director |
Mr. Niraj Agnihotri | Whole Time Director |
Mr. Shanti Prashad Jain | Independent Director |
Mr. Shailendra Swarup | Independent Director |
Mr. Om Prakash Lohia | Independent Director |
Mr. Chandra Prakash Jain | Independent Director |
Ms. Vanita Bhargava | Independent Director |
FAQ
What is the intrinsic value of Gujarat Fluorochemicals Ltd?
Gujarat Fluorochemicals Ltd's intrinsic value (as of 05 September 2025) is 2607.96 which is 22.70% lower the current market price of 3,374.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹37,058 Cr. market cap, FY2025-2026 high/low of 4,881/3,100, reserves of ₹7,242 Cr, and liabilities of 10,609 Cr.
What is the Market Cap of Gujarat Fluorochemicals Ltd?
The Market Cap of Gujarat Fluorochemicals Ltd is 37,058 Cr..
What is the current Stock Price of Gujarat Fluorochemicals Ltd as on 05 September 2025?
The current stock price of Gujarat Fluorochemicals Ltd as on 05 September 2025 is 3,374.
What is the High / Low of Gujarat Fluorochemicals Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Gujarat Fluorochemicals Ltd stocks is 4,881/3,100.
What is the Stock P/E of Gujarat Fluorochemicals Ltd?
The Stock P/E of Gujarat Fluorochemicals Ltd is 59.6.
What is the Book Value of Gujarat Fluorochemicals Ltd?
The Book Value of Gujarat Fluorochemicals Ltd is 660.
What is the Dividend Yield of Gujarat Fluorochemicals Ltd?
The Dividend Yield of Gujarat Fluorochemicals Ltd is 0.09 %.
What is the ROCE of Gujarat Fluorochemicals Ltd?
The ROCE of Gujarat Fluorochemicals Ltd is 9.88 %.
What is the ROE of Gujarat Fluorochemicals Ltd?
The ROE of Gujarat Fluorochemicals Ltd is 8.28 %.
What is the Face Value of Gujarat Fluorochemicals Ltd?
The Face Value of Gujarat Fluorochemicals Ltd is 1.00.